Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lexeo Therapeutics, Inc. | Chief Medical Officer | Common Stock | 26.9K | $355K | $13.22 | Feb 2, 2024 | Direct |
Lexeo Therapeutics, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 161K | Feb 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXEO | Lexeo Therapeutics, Inc. | Feb 2, 2024 | 2 | $0 | 4 | Feb 6, 2024 | Chief Medical Officer |
LXEO | Lexeo Therapeutics, Inc. | Nov 2, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Chief Scientific Officer |